In Billing
Feb 19th, 2018
Effective Jan. 1, 2018, newly approved biosimilar biologicals with a common reference product are no longer grouped into the same billing code. This change was finalized in the 2018 Medicare Physician Fee Schedule final rule. Q5102 Replaced with Two New Codes The April 2018 update to the Medicare Physician Fee Schedule Database (MPFSD) includes three ...
In Coding
Jun 11th, 2010
After receiving reports of floating matter in intravenous (IV) bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India, the U.S. Food and Drug Administration (FDA) released a public health alert on May 29 notifying health care professionals that they should not use and should immediately remove from their pharmacy inventories any of the following IV ...
Sep 2nd, 2009
Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. have agreed to pay $2.3 billion to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Department of Justice (DOJ) announced Sept. 2. Pfizer Will Pay $2.3 Billion for Fraudulent Marketing was last modified: July 5th, 2011 by admin ...